Williams CP, Liang MI, Rocque GB, Gidwani R, Caston NE & Pisu M. “Cancer-related financial hardship screening as part of practice transformation.” Medical Care, in press.
Gidwani R & Damberg C. “Changes in U.S. Hospital Financial Performance During the COVID-19 Public Health Emergency: a Longitudinal Analysis.” JAMA Health Forum, 2023. epub before print, in press.
Gidwani R, Kofner A, Uscher-Pine L & Whaley C. “Differences in Telehealth and In-Person Care During COVID-19 Pandemic Between Commercial and Medicaid Enrollees Vary by Managed Care Enrollment.” American Journal of Managed Care, 2023. 29(1): 19-26.
Williams CP, Rocque GB, Caston NE, Gallagher KD, Angove RSM, Anderson E, de Moor JS, Halpern MT, Offodile AC & Gidwani R. “Health insurance and financial hardship in cancer survivors during the COVID-19 pandemic.” PLoS One, 2022. 17(8): e0272740. PMCID: PMC9355233.
Rocque GB, Caston NE, Andrews C, England R, Williams CP, Ingram SA, Azuero A, Gallagher K, Angove R, Anderson E, Balch A, Fletcher FE, Eaton E, Gidwani R. “Vaccine Hesitancy versus Vaccine Behavior in Patients with Chronic Illness.” Journal of Health Care for the Poor and Underserved, 2022; 33(4): 2007-2031.
Russell LB, Santos da Silva LL, Fracalossi de Moraes R, Gidwani R, Mendes Luz, Toscano C. “Effect of Non-pharmaceutical interventions on COVID-19 cases and deaths in Brazil.” Health Affairs, 2022; 41(7): 1005-1012.
Gidwani R, Franks J, Enegela EM, Caston NE, Williams CP, Aswani MS, Azuero A & Rcoque GB. “Survival in the Real World: A National Analysis of Patients Treated for Early-Stage Breast Cancer.” Journal of Oncology Practice, 2022; 18(2): e235-e249.
Rocque G, Caston NE, Franks J, Williams CP, Aswani MS, Azuero A & Gidwani, R. “Clinical trial representativeness and treatment intensity in a real-world sample of women with early stage breast cancer.” Breast Cancer Research and Treatment, 2021; 190(3): 531-540.
Gidwani R, Asch SM, Needleman J, Faricy-Anderson K, Boothryod DB, Illarmo S, Lorenz KA, Patel MI, Hsin G, Ramchandran K, Wagner TH. “End-of-Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration.” Journal of the American Geriatrics Society, 2021; 69(4) 916-923.
Gidwani R & Russell LB. “Estimating Transition Probabilities for Cost-Effectiveness Analyses: Guidance for Decision Modelers.” Pharmacoeconomics, 2020; 38(11): 1153-1164.
* top 10 most-downloaded article for journal in 2022
* top 8 most-downloaded article for journal in 2023
Gidwani-Marszowski R, Faricy-Anderson K, Asch SM, Illarmo S, Ananth L, Patel MI. “Potentially Avoidable Hospitalizations After Chemotherapy: Differences Across Medicare and the Veterans Health Administration.” Cancer, 2020; 126(14): 3297-3302.
Gidwani-Marszowski R, Boothroyd D, Needleman J, Illarmo S, Asch SM. “Comorbidity Assessment is Uneven across VA and Medicare for the Same Patient: Implications for Risk-Adjustment.” Medical Care, 2020; 58(6): 717-721.
Gidwani-Marszowski R, Asch SM, Mor V, Wagner T, Faricy-Anderson K, Illarmo SM, Hsin G, Patel M, Ramchandran K, Lorenz M, Needleman J. “Health System and Beneficiary Costs Associated with Intensive End-of-Life Medical Services.” JAMA Network Open, 2019; 2(9): e1912161
Gidwani-Marszowski R, Owens DK, Lo J, Goldhaber-Fiebert JD, Asch SM, Barnett PG. “The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration.” Applied Health Economics and Health Policy, 2019; 17(4): 513-521.
Haverhals LM, Manheim CE, Mor V, Ersek M, Kinosian B, Lorenz KA, Faricy-Anderson KGidwani-Marszowski R, Nevedal A, Blayney DB, Patel M, Kelly PA, Timko C, Ramchandran K, Asch SM. “The Appropriate Role of Value in Treating Patients with Advanced Cancer: Oncologists’ Perspectives.” Value in Health, 2018; 21(8):931-937.
Barnett PG, Joyce VR, Lo J, Gidwani-Marszowski R, Goldhaber-Fiebert JD, Desai M, Asch SM, Holodniy M, Owens DK. “The effect of interferon-free regimens on disparities in hepatitis C treatment of U.S. veterans.” Value in Health, 2018; 21(8):921-930.
Gidwani[LP1] -Marszowski R, Needleman J, Mor V, Wagner T, Faricy-Anderson K, Boothroyd D, Patel M, Ramchandran K, Murrell SM, Joyce V and Asch SM. “Quality of End-of-Life Care is Higher in VA than in Medicare: An Evaluation of a Dually-Eligible Population.” Health Affairs, 2018; 37(1).
Gidwani R, Rydel T, Nelligan I, Sattler A, Nguyen C, Mahoney MR, Lin S. “Impact of scribes on physician satisfaction, patient satisfaction, and charting efficiency: a randomized controlled trial.” Annals of Family Medicine, 2017; 15: 427-433.
Ersek M, Miller SC, Wagner TH, Thorpe JM, Smith D, Levy CR, Gidwani R, Faricy-Anderson K, Lorenz K, Kinosian B, Mor V. “Associations between Aggressive Care and Bereaved Families’ Evaluation of End-of-life Care in Patients with Non-Small Cell Lung.” Cancer, 2017; 123(16): 3186-94.
Gidwani, R, Nevedal A, Patel M, Blayney DB, Kelly PA, Timko C, Ramchandran K, Asch SM. “The Appropriate Provision of Primary versus Specialist Palliative care to Cancer Patients: Oncologists’ Perspectives.” Journal of Palliative Medicine, 2017; 20(4): 395-403.
Liu S, Barnett P, Holodniy M, Lo J, Joyce VR, Gidwani R, Asch SM, Owens D, Goldhaber-Fiebert JD. “Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Infection in non-VA and VA Populations.’ Medical Care Policy & Practice, 2016; 1(1): 2381468316671946.
Mor V, Joyce NR, Cote DL, Gidwani RA, Ersek M, Levy CR, Faricy-Anderson KE, Miller SC, Wagner TH, Kinosian BP, Lorenz KA, Shreve ST. “The rise of concurrent care for veterans with advanced cancer at the end of life.” Cancer, 2016; 122(5): 782-90.
Harris AHS, Bowe T, Hagedorn H, Nevedal A, Finlay AK, Gidwani R, Rosen C, Kay C, Christopher M. “Multifaceted Academic Detailing Program to Increase Pharmacotherapy for Alcohol Use Disorder: Interrupted Time Series Evaluation of Effectiveness.” Addiction Science & Clinical Practice, 2016; 11(1): 15.
Gidwani R, Joyce N, Kinosian B, Faricy-Anderson K, Levy C, Miller SC, Ersek M, Wagner T, Mor V. “Gap between Recommendations and Practice of Palliative Care and Hospice in Cancer Patients.” Journal of Palliative Medicine, 2016; 19(9): 957-963.
Avoundjian T, Gidwani R, Yao D, Lo J, Sinnott P, Thakur N, Barnett PG. “Evaluating two measures of LS MRI overuse: administrative data versus chart review.” Journal of the American College Radiology. 2016; 13(9):1057-66.
Gidwani R, Sinnott P, Avoundjian T, Lo J, Asch SM, Barnett PG. “Inappropriate ordering of lumbar spine magnetic resonance imaging: are providers Choosing Wisely?” American Journal of Managed Care. 2016; 22(2): e68-76.
Gidwani R and Zulman, D. “Association Between Acute Medical Exacerbations and Consuming or Producing Web-Based Health Information: Analysis From Pew Survey Data.” Journal of Medical Internet Research, 2015; 17(6): e145.
Gidwani R and Bhattacharya J. “CMS Payment Reform and the Incidence of Hospital-Acquired Pulmonary Embolism or Deep Vein Thrombosis.” Journal of General Internal Medicine, 2015; 30(5): 588-596.
Gidwani R, Barnett P, Goldhaber-Fiebert JD, Asch S, Lo J, Dally S, Owens DK. “Uptake and Utilization of Directly-Acting Antiviral Medications for Hepatitis C Infection in U.S. Veterans.” Journal of Viral Hepatitis. 2015; 22(5): 489-495.
Veeravagu A, Cole T, Jiang B, Ratliff J, Gidwani R. “The Use of Bone Morphogenetic Protein in Thoracolumbar Spine Procedures: Analysis of the Marketscan Longitudinal Database.” The Spine Journal. 2014; 14(12): 2929-2937.
Hoaglin DH, Filonenko A, Glickman M, Wasiak R, Gidwani R. “Use of Multiple-Treatment-Comparison Methods in Estimating Efficacy of Treatments for Heavy Menstrual Bleeding.” European Journal of Medical Research. 2013; 18(1): 17.
Ganz M, Shah D, Gidwani R, Filonenko A, Su W, Pocoski J, Law A. “The cost-effectiveness of the Levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.” Value in Health. 2013; 16(2): 325-333.
Gidwani R, Khan ZM, Fenaux P, Beach CL & Pashos CL. “A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromes.” Journal of Medical Economics. 2012; 15(1): 145-154.
Gidwani R, Goetz MD, Kominski G, Asch SM, Mattocks K, Samet JH, Justice A, Gandhi N & Needleman J. “A Budget Impact Analysis of Rapid HIV Screening in Veterans Administration Emergency Departments.” Journal of Emergency Medicine. 2012; 42(6): 719-726.
Foster TS, Miller JD, Boye ME, Blieden MB, Gidwani R & Russell MW. “The economic burden of metastatic breast cancer: A systematic review of literature from developed countries.” Cancer Treatment Reviews. 2011; 37(6): 405-415.
Chen JC, Goetz MB, Feld JE, Taylor A, Anaya H, Burges J, Flores de Mesa R, Gidwani RA, Knapp H, Ocampo EH & Asch SM. “A provider participatory implementation model for HIV testing in an ED.” American Journal of Emergency Medicine. 2011; 29(4): 418-426.
Gidwani R. “Coca Production and Eradication in Bolivia: Effects of IMF and US Policies on Economic Progress and Human Rights” Journal of the Bolivian Studies Association. 2003; 3(2): 5-34.
Gidwani-Marszowski R, Levy C. “The Experience of Providing Hospice Care Concurrent with Cancer Treatment in the VA.” Supportive Care in Cancer, 2019; 27(4): 1263-1270.
Mor V, Wagner TH, Levy C, Erek M, Miller SC Gidwani-Marszowski R, Joyce N, Faricy-Anderson K, Corneau EA, Lorenz K, Kinosian B, Shreve S. “Association of Expanded VA Hospice Care with Aggressive Care and Cost for Veterans with Advanced Lung Cancer.” JAMA Oncology, 2019; 5(6): 810-816.
Gidwani-Marszowski R, Kinosian B, Scott W, Phibbs C, Intrator O. “Hospice Care in Medicare Advantage versus Traditional Medicare Among Veterans: a Risk-Adjusted Analysis.” Journal of the American Geriatrics Society, 2018; 66(8): 1508-1514.